Human monocyte-derived suppressive cells (humosc) for cell therapy in giant cell arteritis

HIGHLIGHTS

• who: Maxime Samson and colleagues from the University Medical Center Groningen, Hou0302pital Cochin, France have published the research: Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis, in the Journal: (JOURNAL)
• what: The authors show that HuMoSCs could be recruited in the arterial wall through the implication of CCR5 and its ligands. frontiersin.org 10.3389/fimmu.2023.1137794 Conclusions: Altogether, the results suggest that HuMoSCs or their supernatant could be useful to decrease vascular in flammation and remodeling in GCA, the latter being an unmet need in GCA treatment. Autologous . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.